Ascites: its correction by peritoneovenous shunting
- PMID: 371915
- DOI: 10.1016/s0011-3840(79)80001-5
Ascites: its correction by peritoneovenous shunting
Abstract
Patients with refractory ascites and HRS should be considered to present an urgent indication for peritoneovenous shunting. The shunt offers a method of continuous reinfusion of ascitic fluid which corrects avid sodium retention, oliguria and azotemia. Severe encephalopathy, jaundice or peritoneal sepsis--common complications of cirrhosis--contraindicate installation of the shunt before improvement occurs. Associated cardiac disease does not contraindicate the use of the shunt provided that ascitic fluid is removed at the time of operation and large amounts of diuretics are used. This operation has also proved useful in ascites attributed to causes other than cirrhosis. The main complications include disseminated intravascular coagulopathy, hepatic coma and sepsis in a few patients. Results of a randomized prospective study indicate that the shunt should probably be considered in patients with diet-resistant massive ascites even before they prove to be refractory to diuretic therapy.
Similar articles
-
Peritoneovenous (LeVeen) shunt. Control of renin-aldosterone system in cirrhotic ascites.JAMA. 1978 Jan 2;239(1):31-3. doi: 10.1001/jama.239.1.31. JAMA. 1978. PMID: 579228
-
Refractory ascites in cirrhosis.Kidney Int. 1978 Jul;14(1):93-102. doi: 10.1038/ki.1978.94. Kidney Int. 1978. PMID: 682430 No abstract available.
-
Peritoneovenous shunting for ascites.Surg Gynecol Obstet. 1977 Sep;145(3):419-24. Surg Gynecol Obstet. 1977. PMID: 888064
-
Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.Gastroenterol Clin North Am. 1992 Mar;21(1):237-56. Gastroenterol Clin North Am. 1992. PMID: 1568775 Review.
-
The peritoneovenous shunt: expectations and reality.Am J Gastroenterol. 1990 Aug;85(8):917-29. Am J Gastroenterol. 1990. PMID: 2197858 Review.
Cited by
-
Implantation of a skin graft tube to create a saphenoperitoneal shunt for refractory ascites.Surg Today. 2007;37(7):622-5. doi: 10.1007/s00595-006-3471-7. Epub 2007 Jun 26. Surg Today. 2007. PMID: 17593487
-
Rivaroxaban-calibrated chromogenic anti-Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation.Res Pract Thromb Haemost. 2021 Oct 8;5(7):e12594. doi: 10.1002/rth2.12594. eCollection 2021 Oct. Res Pract Thromb Haemost. 2021. PMID: 34646974 Free PMC article.
-
Experimental and clinical experiences with peritoneo-venous shunt (locally made Z-CI device) in the treatment of intractable ascites.Acta Acad Med Wuhan. 1983;3(4):193-8. doi: 10.1007/BF02856877. Acta Acad Med Wuhan. 1983. PMID: 6646551 No abstract available.
-
General surgery-important advances in clinical medicine: ascites and the peritoneovenous shunt.West J Med. 1983 Feb;138(2):248. West J Med. 1983. PMID: 18749301 Free PMC article. No abstract available.
-
[Peritoneovenous shunt in the treatment of therapy-refractory ascites].Langenbecks Arch Chir. 1988;373(1):47-56. doi: 10.1007/BF01263261. Langenbecks Arch Chir. 1988. PMID: 3282133 Review. German. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources